Ryan Phillips
Associate Director, Head of Supply Chain & Strategic Sourcing Precision BioSciences
Seminars
Thursday 1st October 2026
Part 2: Designing Resilient CDMO & Supply Chain Partnerships to Enable Rapid Scale-Up from Clinical to Pivotal for mRNA–LNP Therapies
9:20 am
- Building partnership models that go beyond single-CDMO reliance, including how to qualify and balance primary and backup manufacturers without overextending budget or timelines
- Aligning early with CDMOs on process characterisation, PPQ strategy, batch sizing and scale-up assumptions to avoid revalidation risks and ensure readiness for rapid progression into pivotal studies
- Integrating supply chain and licensing considerations into partnership strategy, including critical raw materials, IP constraints and long-term commercial implications that are often locked in earlier than anticipated
